FIELD: medicine.
SUBSTANCE: method involves applying eradicative drug therapy and magnetic laser transcutaneous therapy with infrared laser radiation of wavelength 0.89 mcm and permanent magnetic field of 150 mTesla units. Running variable magnetic field is concurrently applied with maximum instantaneous amplitude intensity value of 35 mTesla units. The treatment is applied to epigastric region once during a session 2-4 min long daily. The total treatment course is 5-10 sessions long.
EFFECT: stable remission; accelerated stomach mucous membrane defect healing.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF HELICOBACTER PYLORI ERADICATION IN PERIODONTAL TISSUES | 2009 |
|
RU2394617C1 |
METHOD FOR TREATING ULCEROUS GASTRIC AND DUODENAL DISEASE | 1999 |
|
RU2189215C2 |
METHOD OF MEDICAL TREATMENT OF DUODENAL ULCER ASSOCIATED WITH Helicobacter pylori | 2006 |
|
RU2325918C2 |
METHOD FOR PREDICTING GASTRODUODENAL PATHOLOGY DEVELOPMENT COURSE SEVERITY | 1999 |
|
RU2150705C1 |
METHOD FOR TREATING CHRONIC GASTRITIS ASSOCIATED WITH HELICOBACTER INFECTION | 2007 |
|
RU2373972C2 |
METHOD OF TREATING Helicobacter pylori ASSOCIATED CHRONIC EROSIVE GASTRITIS | 2009 |
|
RU2403925C1 |
METHOD FOR TREATING HELICOBACTER-ASSOCIATED CHRONIC DUODENAL ULCER | 2003 |
|
RU2252777C2 |
METHOD OF TREATING Helicobacter pylori ASSOCIATED CHRONIC ULCEROUS DISEASE OF STOMACH AND DUODENUM | 2010 |
|
RU2416408C1 |
TREATMENT OF INFLAMMATORY GASTROINTESTINAL DISEASED ASSOCIATED WITH HELICOBACTER PYLORI | 2004 |
|
RU2278682C2 |
METHOD FOR TREATING SUTURED PERFORATED GASTRODUODENAL ULCERS | 2006 |
|
RU2315604C1 |
Authors
Dates
2006-12-20—Published
2005-08-10—Filed